Pharmacyte Biotech Inc (PMCB) stock has fallen -26.17% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives PMCB stock a score of 18 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 22. PMCB's rank also includes a short-term technical score of 32. PMCB has an Overall Score of 18. Find out what this means to you and get the rest of the rankings on PMCB!